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Jacquelyn L. Meyers, PhD, Erin C. Dunn, ScD, MPH, Silvia S. Martins, MD, PhDObjective: Although potentially traumatic events (PTEs)
are established risk factors for substance use disorders
among adults, little is known about associations with drug
use during adolescence, an important developmental
stage for drug use prevention. We examined whether
childhood PTEs were associated with illicit drug use
among a representative sample of US adolescents.
Method: Data were drawn from the National Comor-
bidity Survey Replication–Adolescent Supplement (NCS-
A), which included adolescents aged 13 to 18 years
(N ¼ 9,956). Weighted logistic regression models esti-
mated risk ratios for lifetime use of marijuana, cocaine,
nonmedical prescription drugs, other drugs, and multiple
drugs.
Results: Exposure to any PTE before age 11 years was
reported by 36% of the sample and was associated with
higher risk for use of marijuana (risk ratio [RR] ¼ 1.50),
cocaine (RR ¼ 2.78), prescription drugs (RR ¼ 1.80), other
drugs (RR ¼ 1.90), and multiple drugs (RR ¼ 1.74). A
positive monotonic relationship was observed betweenThis article is discussed in an editorial by Dr. Christopher J. Hammond
on page 643.
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at www.jaacap.org.
OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
E 55 NUMBER 8 AUGUST 2016number of PTEs and marijuana, other drug, and multiple
drug use. Interpersonal violence was associated with all
drug use outcomes. Accidents and unspecified events
were associated with higher risk for marijuana, cocaine,
and prescription drug use.
Conclusion: Potentially traumatic events in childhood are
associated with risk for illicit drug use among US ado-
lescents. These findings add to the literature by illustrating
a potentially modifiable health behavior that may be a
target for intervention. The results also highlight that ad-
olescents with a trauma history are a high-risk group for
illicit drug use and may benefit from trauma-focused
prevention efforts that specifically address traumatic
memories and coping strategies for dealing with stressful
life events.
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childhood trauma, maltreatment
J Am Acad Child Adolesc Psychiatry 2016;55(8):701–708.he average age of first use of illicit drugs is during late
adolescence to early adulthood,1 making adolescenceT an important developmental stage for education and
interventions to prevent substance use and disorders.1,2 In
particular, earlier age at initiation and patterns of substance
use in adolescence may have a lasting influence on substance
use and disorders across the life course.3,4 To develop and
provide effective drug prevention programming to youth, it
is necessary to identify adolescents at particularly high risk
for illicit drug use5,6 and to investigate the factors that create
this higher risk.
Although potentially traumatic events (PTEs) in child-
hood are established risk factors for substance use disorders
in adults,7-12 scant research has examined the associations of
childhood PTEs with initiation of substance use in adoles-
cence. To our knowledge, only 4 previous studies have
explicitly examined the role of family adversity andmaltreatment on substance use in adolescence. Taken
together, these studies reported that aspects of family
adversity were associated with earlier age of drug and
alcohol use initiation,3,7,8,13 heavier alcohol use among boys
reporting sexual assault,13 and drinking as a coping
behavior.3 However, prior studies have been limited in
several ways. First, prior studies have focused exclusively on
childhood maltreatment and family dysfunction without
examining other forms of trauma exposure,3,7,8,13 even
though potentially traumatic events experienced outside the
home are strong predictors of mental health and substance
use outcomes in adult populations.14-19 Second, these studies
have relied largely on the retrospective reports of adults
about maltreatment and substance use in childhood and
adolescence,3,7,8 which decrease in accuracy with increasing
age.20-22 Third, most studies have assessed clinical or con-
venience samples,7,8,13 limiting the potential to provide
population estimates for the efficacy of any interventions or
policy changes, and precluding conclusions as to whether
these associations would persist among more diverse sam-
ples. Fourth, to our knowledge, no prior studies have
examined effects across specific types of illicit drugs that
could help in understanding the etiology of drug use prob-
lems and in targeting interventions to prevent adolescentwww.jaacap.org 701
CARLINER et al.drug use.23,24 Fifth, no studies have examined whether as-
sociations between PTEs and adolescent drug use are
equivalent for individuals with or without comorbid psy-
chiatric disorders, even though there is robust evidence of
multifinality following exposure to PTEs,25-27 particularly for
posttraumatic stress disorder (PTSD) and substance use.28-30
Finally, prior studies have not controlled for the potential
confounding or moderating effects of parental substance
misuse in estimates of substance use outcomes9,13 or have
treated parental substance misuse as a direct form of
adversity.3,7,10 Parental substance misuse could confound
the association between childhood PTEs and adolescent
drug use because of its association with exposure to a
dysfunctional home environment, family violence, and other
forms of trauma,31,32 as well as its influence on adolescent
drug use through biological predisposition, access to drugs
in the home, modeling behavior, low parental involvement,
and social acceptability.3,6,33-38 Furthermore, parental sub-
stance misuse could also moderate the association between
PTEs and drug use because adolescents with a parent who
misuses substances could be at higher risk for drug use due
to predisposition, access, and modeling.
In summary, this is the first study, to our knowledge, to
examine associations between a broad range of traumatic
events in childhood with specific types of drug use in a
nationally representative sample of adolescents, adjusting
for parental substance misuse. We examine PTEs experi-
enced during childhood and their associations with drug use
in adolescence, independent of any proximal traumatic
stressors occurring simultaneously with drug use. We focus
on trauma exposure prior to age 11 years, as this is the age
when most US adolescents transition from elementary to
middle school, with the related exposure to older students,
more independence, and potentially greater opportunities
for using illicit drugs.5,6,39-41 In secondary analyses, we also
assessed whether any associations persisted among adoles-
cents reporting parental substance misuse or diagnosed with
distress or behavior disorders. Data were drawn from the
National Comorbidity Survey Replication–Adolescent Sup-
plement (NCS-A). The primary aim of this study was to
examine the association between multiple types of PTEs in
childhood with use of various illicit drugs in adolescence. In
addition, we also determined the role of parental substance
misuse in these associations.
METHOD
Study Design and Sample
The National Comorbidity Survey–Adolescent Supplement (NCS-A)
was conducted between 2001 and 2004. Adolescents were selected
from households participating in the National Comorbidity Survey
Replication (NCS-R) at a response rate of 86.8% (879 adolescents).
An additional sample was derived from schools at a response rate of
82.6% (9,244 adolescents). The total NCS-A sample was 10,123
English-speaking adolescents who were 13 to 18 years of age. Data
were weighted for variability in probability of selection and differ-
ential nonresponse based on population sociodemographic distri-
butions. Merged weighted household and school samples were
adjusted for design effects, and closely approximate the socio-
demographic distribution of the 2000 US Census population.42-44702 www.jaacap.orgAdditional details about the survey design and sampling pro-
cedures are provided elsewhere.43-45 For the current study, we
excluded any participant who was missing a response for any of the
PTEs or survey stratification variables, creating a final analytic
sample of 9,956 adolescents (98.4%). Written informed consent from
parents and assent from adolescents were obtained from all partic-
ipants. Study procedures were approved by Human Subjects
Committees at Harvard Medical School and the University of
Michigan. The current study was approved by the Human Subjects
Committee at Columbia University.
Measures
Exposure: Potentially Traumatic Events. Potentially traumatic events
assessed in this study included items from the Criterion A1 assess-
ment for PTSD included in the Composite International Diagnostic
Interview (CIDI) portion of the NCS-A.46 The CIDI for DSM-IV is a
fully structured diagnostic instrument administered by trained lay
interviewers.47 Following prior work in this sample and others
showing differential consequences of certain traumatic event
types,10,44,48,49 Criterion A1 PTEs were grouped into the following
categories: interpersonal violence (physical abuse by caregiver,
physical assault by someone else, mugged, raped, sexually assaul-
ted, stalked, kidnapped, or exposed to domestic violence), traumatic
accidents (car accident, other serious accident, natural or manmade
disaster, physical illness, toxic chemical exposure, or having acci-
dentally injured someone), network or witnessing events (unex-
pected death of a loved one, traumatic experience of a loved one, or
witnessing injury or death), and other events. This final category
included a question from the PTSD instrument asking, “Did you
ever experience any other extremely upsetting or life-threatening
event that I haven’t asked about yet?” and a question about
events that the participant did not feel comfortable disclosing to the
interviewer. Although we lack details of the event type for this
measure, prior studies have shown this “other” category to be
particularly highly associated with psychiatric disorders.44 We
created a variable to assess exposure to any PTE, and a count var-
iable assessing exposure to no PTEs, to only 1 PTE type, 2 PTE types,
and 3 or more PTE types (due to low frequencies above this num-
ber), based on the original 19 items from the PTSD checklist.
Outcome: Lifetime Illicit Drug Use. Adolescents were asked
whether they had ever (even once) used a list of illicit drugs.45,50
Respondents were asked about the following: marijuana or hash-
ish; cocaine in any form (including powder, crack, free base, coca
leaves, or paste); tranquilizers, stimulants, painkillers, or other pre-
scription drugs either without the recommendation of a health
professional, or for any reason other than a health professional said
they should be used; and heroin, opium, glue, LSD, peyote, or any
other drug. We created a dichotomous variable for polydrug use by
combining affirmative responses from the above list, and assigning a
“yes” value if participants endorsed use of more than one drug type.
To establish temporality between our exposures and outcomes, to
focus on trauma experienced during childhood as a distinct devel-
opmental stage, and to capture the initiation of drug use among the
vast majority of our sample, we assessed only PTEs with the first
occurrence before age 11 years (74% of events), and excluded drug use
with first occurrence before age 11 years (<1% of the sample).
Moderation and Control Variables. Baseline demographic control
variables included sex, age (continuous), race/ethnicity (non-
Hispanic white, non-Hispanic black, Hispanic, other), and parent
income (low income, low-middle income, high-middle income, high
income). Final regression models also controlled for possible con-
founding by parent substance misuse (combined binary measure of
adolescents’ reports of problem drinking or drug use for mothers or
fathers). Interaction terms were constructed to assess moderation ofJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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TABLE 1 Prevalencea of Potentially Traumatic Events (PTE) and
Lifetime Illicit Drug Use Among Adolescents in the National







Interpersonal violence 11.06 (0.63)
Accident 18.16 (0.73)
Witnessing/network event 14.61 (0.66)
Other/nondisclosed event 3.85 (0.25)
Any PTE 35.60 (0.88)
One PTE 23.33 (0.57)
Two PTEs 7.67 (0.54)
Three or more PTEs 4.48 (0.31)





Other drugs 3.07 (0.42)
Multiple illicit drugs 6.31 (0.59)
Note: Interpersonal violence includes physical abuse by caregiver, or physical
assault by someone else, having been mugged, raped, sexually assaulted,
stalked, kidnapped, or exposed to domestic violence. Traumatic accidents
include car accident, other serious accident, natural or manmade disaster,
physical illness, toxic chemical exposure, or having accidentally injured
someone. Network or witnessing events include unexpected death of a
loved one, traumatic experience of a loved one, or witnessing injury or
death. Other events include events not listed and undisclosed events.
aWeighted percentage (standard error).
CHILD TRAUMA AND DRUG USE IN ADOLESCENCEthe association between PTEs and drug use by parent substance
misuse, as well as by lifetime distress disorder (DSM-IV diagnosis
of social anxiety disorder, PTSD, dysthymia, major depression,
or generalized anxiety disorder) and lifetime behavior disorder
(DSM-IV diagnosis of attention-deficit/hyperactivity disorder,
oppositional defiant disorder, conduct disorder, anorexia nervosa,
bulimia, or binge eating disorder), using classifications based on
prior factor analyses in this sample.51
Statistical Analysis
After assessing univariate and bivariate statistics for the full sample,
we estimated logistic regression models for the association between
PTEs and lifetime prevalence of drug use among adolescents. First,
we estimated the association between any PTE and the 5 drugs of
interest, controlling for baseline demographic variables. We then
controlled for parent substance misuse in these models. We repeated
these steps using a categorical variable for number of PTEs reported
(0, 1, 2, 3 or more) and for specific categories of PTEs. Finally, we
assessed statistical interaction between PTEs and parental substance
misuse, adolescent distress disorder, and adolescent behavior dis-
order. For any significant interaction, regression models were
stratified by the moderator of interest. Sensitivity analyses assessed
whether effect estimates changed when controlling for all PTE types
in the same model simultaneously.
Due to the high prevalence of some outcomes, odds ratios
obtained from logistic regression models were converted to model-
adjusted risk ratios using predicted marginals.52,53 Results are
presented as adjusted risk ratios (RR) and 95% CIs. All analyses
were conducted to account for the complex survey design of the
NCS-A, and included sample weights to account for differential
probability of selection and to be nationally representative based on
sociodemographic characteristics. Analyses were conducted using
SAS-callable SUDAAN version 11.0 (Research Triangle Institute,
Research Triangle Park, NC; 2012).RESULTS
Prevalences of sociodemographic variables in this sample
have been reported previously, and are representative of the
2000 US Census population.54 Before age 11 years, 36% of
participants had experienced at least 1 PTE, 23% reported
only 1 type of PTE, 8% reported 2, and 4% reported 3 or
more (Table 1). Before the age of 11 years, 11% of partici-
pants had experienced interpersonal violence, 18% had had
a traumatic accident, 15% had witnessed or heard about a
traumatic event happening to a loved one, and 4% reported
an unspecified event. For lifetime drug use, 22% had ever
used marijuana, 2% cocaine, 5% prescription drugs not for
medical reasons, 3% other drugs, and 6% multiple drugs.
Specific Event Types and Drug Use
Exposure to interpersonal violence before the age of 11 years
was associated with higher risk for lifetime use of all drug
types, controlling for demographic covariates (Table 2).
These effects were attenuated after controlling for parent
substance misuse, but associations remained statistically
significant. Interpersonal violence was associated with use of
marijuana (RR ¼ 1.78, CI ¼ 1.542.07), cocaine (RR ¼ 2.64,
CI ¼ 1.753.98), nonmedical prescription drugs (RR ¼ 2.20,
CI ¼ 1.493.27), other drugs (RR ¼ 1.70, CI ¼ 1.122.57),
and multiple drugs (RR ¼ 2.31, CI ¼ 1.693.15).JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 8 AUGUST 2016In baseline models, exposure to traumatic accidents was
associated with higher risk for lifetime marijuana, cocaine,
and other drug use. After controlling for parent substance
misuse, effect sizes were attenuated, and only cocaine use
remained statistically significant. Witnessing a traumatic
event or hearing about the PTEs of loved ones was associ-
ated with higher risk for marijuana and other drug use in
baseline models. However, none of these associations
remained significant after controlling for parent substance
misuse. Unspecified PTEs were associated with higher risk
for all types of drug use except cocaine in baseline models.
After controlling for parent substance misuse, other PTEs
were associated with higher risk for marijuana use
(RR ¼ 1.48, CI ¼ 1.141.93) and cocaine use (RR ¼ 1.84,
CI ¼ 1.212.80).
Sensitivity analyses assessed whether these associations
persisted when simultaneously estimating all 4 PTE classes
in the same regression models. We found that effect sizes
were slightly attenuated in all models, but no tests of sta-
tistical significance of PTE exposure classes were changed in
any instance (results not shown). Therefore, independent of
exposure to other types of PTEs, all reported associations
remained statistically significant for unique PTE exposures.
Number of Traumatic Events and Drug Use
Controlling for demographic covariates, exposure to any
PTE before the age of 11 years was associated with higherwww.jaacap.org 703
TABLE 2 Risk of Lifetime Illicit Drug Use by Exposure to Potentially Traumatic Events (PTE) Among Adolescents in the National
Comorbidity Survey–Adolescent Supplement (N ¼ 9,956)
Potentially Traumatic
Eventsa













Model 1 1.98 (1.74e2.26)* 3.88 (2.81e5.37)* 2.66 (1.84e3.83)* 2.29 (1.57e3.34)* 2.81 (2.12e3.71)*
Model 2 1.78 (1.54e2.07)* 2.64 (1.75e3.98)* 2.20 (1.49e3.27)* 1.70 (1.12e2.57)* 2.31 (1.69e3.15)*
Accidental
Model 1 1.22 (1.03e1.44)* 2.34 (1.49e3.67)* 1.40 (0.86e2.28) 1.59 (1.08e2.34)* 1.35 (0.98e1.86)
Model 2 1.12 (0.94e1.33) 2.13 (1.34e3.38)* 1.22 (0.75e2.01) 1.40 (0.96e2.03) 1.20 (0.88e1.65)
Witnessing
Model 1 1.29 (1.07e1.55)* 1.20 (0.83e1.72) 1.18 (0.85e1.64) 1.58 (1.07e2.33)* 1.25 (0.95e1.65)
Model 2 1.17 (0.99e1.38) 0.92 (0.58e1.46) 1.09 (0.78e1.52) 1.45 (0.97e2.17) 1.11 (0.83e1.47)
Other
Model 1 1.65 (1.31e2.09)* 1.45 (0.71e2.96) 2.19 (1.49e3.22)* 1.88 (1.15e3.05)* 1.79 (1.19e2.69)*
Model 2 1.48 (1.14e1.93)* 1.14 (0.56e2.31) 1.84 (1.21e2.80)* 1.58 (0.95e2.65) 1.46 (0.93e2.28)
Any PTE
Model 1 1.50 (1.33e1.69)* 2.78 (1.95e3.97)* 1.80 (1.29e2.51)* 1.90 (1.37e2.63)* 1.74 (1.37e2.20)*
Model 2 1.34 (1.20e1.50)* 2.17 (1.48e3.17)* 1.50 (1.07e2.10)* 1.58 (1.12e2.23)* 1.45 (1.14e1.84)*
One PTE
Model 1 1.32 (1.19e1.48)* 2.13 (1.26e3.58)* 1.50 (1.02e2.20)* 1.56 (1.03e2.36)* 1.38 (1.02e1.87)*
Model 2 1.22 (1.11e1.35)* 1.98 (1.21e3.25)* 1.34 (0.91e1.98) 1.42 (0.95e2.14) 1.25 (0.94e1.68)
Two PTEs
Model 1 1.65 (1.37e1.99)* 4.23 (2.73e6.55)* 1.90 (1.20e3.01)* 2.11 (1.32e3.39)* 2.25 (1.57e3.21)*
Model 2 1.41 (1.15e1.72)* 2.61 (1.44e4.73)* 1.38 (0.81e2.33) 1.49 (0.82e2.73) 1.62 (1.04e2.52)*
Three or more PTEs
Model 1 2.17 (1.72e2.74)* 3.58 (1.88e6.81)* 3.14 (1.95e5.06)* 3.26 (2.05e5.19)* 2.69 (1.82e3.97)*
Model 2 1.89 (1.47e2.43)* 2.24 (1.18e4.22)* 2.50 (1.53e4.09)* 2.51 (1.54e4.10)* 2.14 (1.41e3.23)*
Note: Model 1 logistic regression results adjusted for age, sex, race/ethnicity, and parent income; Model 2 logistic regression results adjusted for age, sex, race/
ethnicity, parent income, and parent substance misuse.
aFor specific event types and “Any PTE” models, the reference group is participants who reported no PTEs of that type. For number of PTEs, the reference group is
participants who reported no PTEs, and the number of PTEs are included as a single categorical variable in each model.
*p < .05.
CARLINER et al.risk for lifetime use of marijuana (RR ¼ 1.50,
CI ¼ 1.331.69), cocaine (RR ¼ 2.78, CI ¼ 1.953.97),
nonmedical prescription drugs (RR ¼ 1.80, CI ¼ 1.292.51),
other drugs (RR ¼ 1.90, CI ¼ 1.372.63), and multiple drugs
(RR ¼ 1.74, CI ¼ 1.372.20) (Table 2). Controlling for parent
substance misuse attenuated these effect estimates; however,
all remained statistically significant. There was evidence of a
positive monotonic relationship for number of PTEs experi-
enced and risk of marijuana, other drug, and polydrug use
(Figure 1). Controlling for demographic covariates and
parent substance misuse, any 1, 2, and 3 or more childhood
PTEs reported were all statistically associated with higher
risk for marijuana and cocaine use.
Moderation by Parent Substance Misuse and Adolescent
Psychiatric Disorders
Our results indicated that parental substance misuse largely
failed to moderate the association between PTEs and
adolescent drug use. Significant interactions were observed704 www.jaacap.orgonly for 2 drug use types. Adolescents reporting parent
substance misuse were at higher risk for lifetime marijuana
use associated with other PTEs (RR ¼ 1.63, CI ¼ 1.282.07),
compared to adolescents reporting no parent substance
misuse (RR ¼ 1.38, CI ¼ 1.001.90; pinteraction ¼ .046). Ado-
lescents reporting parent substance misuse were also at
higher risk for use of other drugs associated with interper-
sonal PTEs (pinteraction ¼ .02), any PTE (pinteraction ¼ .02), and
number of PTEs (pinteraction ¼ .001), compared to adolescents
not reporting parent substance misuse.
Similarly, adolescent distress disorders and behavioral
disorders mostly did not moderate the associations between
PTEs and drug use. The single exception was for interper-
sonal violence PTEs and nonmedical prescription drug use,
where adolescents without a history of behavior disorder
were at higher risk for prescription drug use (RR ¼ 3.00,
CI ¼ 1.924.70) compared to adolescents with a history of
behavior disorder (RR ¼ 1.45, CI ¼ 0.952.22;
pinteraction ¼ .0008).JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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FIGURE 1 Adjusted risk ratios and 95% CIs for lifetime illicit drug use associated with number of potentially traumatic experiences
before age 11 among adolescents in the National Comorbidity Survey–Adolescent Supplement (N ¼ 9,956). Note: For each model,
the reference group is adolescents exposed to no potentially traumatic events (PTEs) prior to age 11. All models adjusted for age,
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CHILD TRAUMA AND DRUG USE IN ADOLESCENCEDISCUSSION
In this population-representative sample of US adolescents,
exposure to any PTE in childhood was associated with
higher risk for lifetime use of all illicit drugs assessed. We
found evidence for a doseresponse relationship between
number of PTEs experienced and marijuana, other drug, and
polydrug use. Interpersonal violence experienced in child-
hood was consistently associated with lifetime use of all
illicit drugs assessed, even after controlling for the con-
founding effect of parent substance misuse, which attenu-
ated the effect sizes of many of the associations assessed. To
our knowledge, this is the first population-based study to
report that traumatic events other than childhood maltreat-
ment are associated with higher risk for marijuana, cocaine,
and nonmedical prescription drug use among adolescents.
Consistent with prior research using both the NCS-A and
the adult sample of the National Comorbidity Survey
(NCS-R), childhood maltreatment and interpersonal violence
are strongly associated with multiple psychiatric and
behavioral outcomes.10,11,44,46 Combined with results from
previous studies on diverse health outcomes, our findings
here confirm that these forms of physical and sexual violence
exhibit multifinality in that they are associated with elevated
risk for multiple adverse outcomes, including health
behaviors, not only diagnosed disorders.44,46,48 Health
behaviors such as adolescent drug use may be modifiable
risk factors that can be targeted to prevent future adverse
health outcomes.55 Efforts to prevent the particularly devas-
tating forms of trauma such as physical, sexual, and domestic
violence should be at the forefront. Researchers should
continue to explore risk factors for the perpetration of this
violence so as to inform policy and social welfare initiatives
with an evidence-based primary prevention approach.JOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 8 AUGUST 2016Although our measure of interpersonal violence
comprised many of the indicators that are usually included
in studies of childhood maltreatment (i.e., physical and
sexual assault, domestic violence), our results also indicate
that other forms of trauma are also associated with illicit
drug use in adolescents when interpersonal violence expo-
sure was controlled for in statistical models. Adolescents
who experienced accidental PTEs were at elevated risk
specifically for cocaine use. Prior work has shown that the
association between unintentional or accidental events and
adverse outcomes are generally less robust.56,57 However,
particularly in an adolescent sample, perhaps these accidents
and illnesses pose more real threat of death than other
events, thus making the “dose” of traumatic stress stronger
in this category.56-60 Future research should try to replicate
these findings to determine whether this specificity of asso-
ciation persists in other populations and, if so, by what
mechanism it may act. Specifically, researchers and clini-
cians should explore the nature of these events and their
consequences, and try to determine whether the specific
association with cocaine use has any relationship to the type
of medical treatment received after these accidents or
illnesses.
Events not disclosed to the survey team by participants
were associated with higher risk for marijuana and
nonmedical prescription drug use, in line with past work
showing that other/private events are associated with onset
of psychiatric disorders and persistence of PTSD.44 This
should be noted by researchers conducting future life events
surveys, if study participants are less likely to report certain
types of traumatic events. Healthcare workers and care-
givers should also be aware of increased risk for drug use
arising from undisclosed traumatic events.www.jaacap.org 705
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and risk of cocaine and nonmedical prescription drug use,
and for traumatic accidents and cocaine use. Future studies
should explore whether these associations are driven by
socio-environmental factors related to access to different
drug types or whether there is something about the psy-
choactive effects of cocaine and some prescription drugs that
is specifically sought by adolescents coping with traumatic
memories.
The substantial confounding by parent substance misuse
that we observed also deserves more attention in future
studies. The associations between interpersonal violence and
drug use outcomes were confounded by parent substance
misuse, indicating a domestic environment with multiple
forms of interrelated traumas for some children. Future
studies should examine the mechanisms by which parental
substance use and exposure to traumatic events are associ-
ated with adolescent substance use, for example through an
influence on social norms and expectancies, modeling
behavior, access to illicit substances, or by providing
opportunity via low parental involvement or neglect.3,6,33-38
These explorations were beyond the scope of the current
study, but future research can inform priorities for inter-
vention in harmful home environments for children and
adolescents. By and large, parent substance misuse did not
affect the associations between PTEs and drug use. Excep-
tions included other PTEs and marijuana use, and interper-
sonal PTEs and other drug use. This could be related to
access to drugs in the home or neighborhood, as marijuana
and certain types of other drugs may be more easily
obtained by adolescents. Alternatively, this statistical inter-
action could represent a constellation of adversity related to
family dysfunction, as discussed in prior studies.10,46 Future
work should use latent variable techniques to further explore
these complex associations and pathways.
Given the breadth of exposures and outcomes assessed in
the current study, it was beyond the scope of this article to
assess the multiple possible mechanisms by which PTEs are
associated with adolescent substance use. Future studies,
ideally using longitudinal data, should continue to explore
these patterns by conducting formal tests of mediation,
assessing indirect effects of PTEs through distress and
behavior disorders on substance use among both boys and
girls. Additional avenues for future work include examina-
tion of the ways in which social norms, peer groups, socio-
demographic factors, and drug availability affect these
associations, and whether any protective factors exist that
could be used to design interventions and educational
campaigns for adolescents.
A number of limitations should be considered in inter-
preting these results. First, all associations reported here
should be interpreted with caution, due to the cross-
sectional nature of the data. However, our results are
consistent with numerous prior studies3,7,8,10 reporting as-
sociations between childhood trauma and drug use out-
comes. Furthermore, the potential for reverse causation is
minimized because we included only PTEs experienced
before the age of 11 years and drug use after the age of
10 years.706 www.jaacap.orgA second concern is the retrospective reporting of both
PTEs and lifetime drug use. Although the potential for recall
bias is reduced in younger participants with shorter lags
between timing of event and reporting of event,20-22 we still
cannot rule out the possibility of underreporting of drug use
due to social desirability bias and underreporting of PTEs
due to forgetting or trauma-related nonacceptance. These
biases could result in either overestimation or underesti-
mation of results reported here. However, the prevalence of
drug use reported in the NCS-A is consistent with or higher
than that reported in other surveys,50,61,62 and the prevalence
of any exposure to PTEs is only slightly lower than that of
adult samples,44,63 suggesting that underreporting may not
be of great concern in this study.
A third concern, as noted above, is that confounding of
the association between PTEs and drug use could be due to
parental substance misuse, for which we adjust in final
models. However, parental substance misuse could also be a
direct outcome of a PTE, if the event was experienced by
both the parent and the child (e.g., death of a loved one, car
accident). Including this variable in statistical models may
therefore induce bias in these estimates. As we are unable to
tease out the temporality of these variables in the NCS-A
dataset, we present models both unadjusted and adjusted
for parental substance misuse, for comparison. We also
conducted interaction tests to assess moderation by parental
substance misuse, and mostly found no significant differ-
ences, as noted above. Future studies should use longitudi-
nal data to further explore these associations.
Fourth, another limitation is common to all studies
using the PTSD Criterion A1 list of PTEs. This list of event
types does not adequately capture the “dose” of the trau-
matic experience, the severity of the event, or the context in
which the event was experienced.64 This makes it difficult
to determine whether familial and sexual violence experi-
ences are more strongly associated with deleterious out-
comes because they are chronic experiences of trauma
occurring within a child’s home, or because the events
themselves are more “toxic.”59 Complementary research
should continue to assess these more qualitative aspects of
traumatic stress.
This study adds to the large body of research doc-
umenting the potentially toxic effects of psychological
trauma to a wide range of behavioral and health outcomes
beyond PTSD. These findings add to the childhood adversity
literature by demonstrating, first, that PTEs experienced in
childhood are associated with drug use in adolescence—a
potentially modifiable health behavior—and therefore a
target for intervention and treatment in youth; and second,
that adolescents with a trauma history are a high-risk group
for illicit drug use and may benefit from prevention efforts
that specifically address traumatic memories and coping
strategies for dealing with stressful life events. Future work
should explore whether adolescents with a trauma history
are more likely to develop chronic or harmful drug use than
their nontraumatized peers. In combination with other signs
and indicators, early drug use can act as a marker for ado-
lescents who may need additional support or intervention.
For clinicians, our results combined with other studies implyJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 55 NUMBER 8 AUGUST 2016
CHILD TRAUMA AND DRUG USE IN ADOLESCENCEthat drug treatment programs may need to more directly
address childhood trauma in their therapeutic approach.
Early interventions targeting coping with trauma during this
critical period of adolescence could have broad benefits to
the health and wellbeing of adults. &
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